September 8, 2023

Randox Laboratories Limited Karena Shaw   
Regulatory Affairs Manager 55 Diamond Road   
County Antrim, BT29 4QY United Kingdom

Re: K230890 Trade/Device Name: ISE Electrodes Regulation Number: 21 CFR 862.1600 Regulation Name: Potassium Test System Regulatory Class: Class II Product Code: CEM, CGZ, JGS Dated: August 11, 2023 Received: August 11, 2023

Dear Karena Shaw:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531- 542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical  
devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn   
(https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Paula V. Caposino -S

Paula Caposino, Ph.D.   
Acting Deputy Director   
Division of Chemistry   
and Toxicology Devices   
OHT7: Office of In Vitro Diagnostics   
Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

510(k) Number (if known) K230890

The ISE Electrodes on the RX Imola can be used for measurement of the electrolytes sodium, potassium and chloride in serum and urine and for use in diagnosis and treatment of electrolyte imbalance.

For in vitro diagnostic use only.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# \*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.”

# SPECIAL 510(k) SUMMARY K230890

# General Information

# Name:

Randox Laboratories Limited

# Address:

55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom.

Telephone: $+ 4 4$ (0) 28 9442 2413   
Fax: $+ 4 4$ (0) 28 9445 2912

Contact: E-mail:

Karena Shaw karena.shaw@randox.com

# Device Identification

# Proprietary Names: ISE Electrodes

Table 1: Candidate Device Regulatory Summary   

<table><tr><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Regulation Name</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>CEM</td><td rowspan=1 colspan=1>Electrode, Ion-Specific,Potassium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>21 CFR 862.1600</td><td rowspan=1 colspan=1>Clinical Chemistry(75)</td></tr><tr><td rowspan=1 colspan=1>CGZ</td><td rowspan=1 colspan=1>Electrode, Ion-Specific,Chloride</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>21 CFR 862.1170</td><td rowspan=1 colspan=1>Clinical Chemistry(75)</td></tr><tr><td rowspan=1 colspan=1>JGS</td><td rowspan=1 colspan=1>Electrode, Ion-Specific,Sodium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>21 CFR 862.1665</td><td rowspan=1 colspan=1>Clinical Chemistry(75)</td></tr></table>

# Predicate Device:

Previously cleared unmodified device: RX imola (k052914)

# DEVICE DESCRIPTION

RX imola is an automated clinical chemistry analyzer complete with dedicated analyzer software. Software functions of the analyzer include the facility to interact with a host computer for direct download of test method selection details for individual samples. A barcode system is used for the rapid identification of patient samples, reagents and QC samples.

In addition, the RX imola is fitted with an Ion Selective Electrode (ISE) module that operates in conjunction with specific electrodes for the quantitative in vitro diagnostic determination of Sodium, Potassium and Chloride in serum and urine.

# INTENDED USE

The ISE Electrodes on the RX Imola can be used for measurement of the electrolytes sodium, potassium and chloride in serum and urine and for use in diagnosis and treatment of electrolyte imbalance.

For in vitro diagnostic use only.

# DESCRIPTION OF MODIFICATION TO EXISTING DEVICE

Following discontinuation of the original ISE unit, the RX imola instruments purchased will now be fitted with a new ISE electrodes for Sodium, Potassium & Chlorides. RX imola instruments fitted with the new ISE electrodes will be identified by an alternate serial number prefix (7255).

The new ISE unit being implemented through this Special 510(k) was previously cleared under k131554 for our RX DAYTONA PLUS CHEMISTRY ANALYZER. The data included in this Special 510(k) summary is based on a comparison of the original ISE electrodes used in conjunction with RX imola (K052914) and the new ISE electrodes that will now be used with the RX imola.

# COMPARISON WITH PREDICATE DEVICE

The following table describes the similarities and differences between

• ISE device originally cleared with the RX imola through K052914 • Candidate ISE device with the RX imola analyser

# Table 2: Comparison with predicate device

# Similarities

# Confidential

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>RX imolaAutomated AnalyzerWith previous ISE unit(ORIGINALLY CLEARED DEVICEK052914)</td><td rowspan=1 colspan=1>RX imolaAutomated AnalyzerWith New ISE Unit(CANDIDATE DEVICEK230890)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Used for measurement of the electrolytessodium, potassium and chloride in serumand urine for diagnosis and treatment ofelectrolyte imbalance</td><td rowspan=1 colspan=1>Used for measurement of the electrolytessodium, potassium and chloride in serum andurine for diagnosis and treatment ofelectrolyte imbalance</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Direct</td><td rowspan=1 colspan=1>Direct</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>CalibrationFrequency</td><td rowspan=1 colspan=1>8 Hours</td><td rowspan=1 colspan=1>8 Hours</td></tr><tr><td></td><td></td><td></td></tr><tr><td rowspan=4 colspan=1>ISEElectrodesUsage[10 000Samples]</td><td rowspan=1 colspan=1>REF: 360 Days</td><td rowspan=1 colspan=1>REF: 360 Days</td></tr><tr><td rowspan=1 colspan=1>Na*: 360 Days</td><td rowspan=1 colspan=1>Na+: 360 Days</td></tr><tr><td rowspan=1 colspan=1>K+: 180 Days</td><td rowspan=1 colspan=1>K+: 180 Days</td></tr><tr><td rowspan=1 colspan=1>Cl: 90 Days</td><td rowspan=1 colspan=1>Cl: 90 Days</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>ISE SampleTypes</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>Urine</td></tr><tr><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>EnvironmentalOperatingTemperature</td><td rowspan=1 colspan=1>15°C to 30°</td><td rowspan=1 colspan=1>15°C to 30°</td></tr></table>

# Page 3 of 15

# Confidential

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>RX imolaAutomated AnalyzerWith previous ISE unit(ORIGINALLY CLEARED DEVICEK052914)</td><td rowspan=1 colspan=1>RX imolaAutomated AnalyzerWith New ISE UnitCANDIDATE DEVICEK230890)</td></tr><tr><td rowspan=1 colspan=1>ISEThroughput</td><td rowspan=1 colspan=1>240 tests per hour</td><td rowspan=1 colspan=1>180 tests per hour</td></tr><tr><td rowspan=10 colspan=1>Consumables</td><td rowspan=1 colspan=1>Medica: Reference Electrode</td><td rowspan=1 colspan=1>Horiba: Reference Electrode</td></tr><tr><td rowspan=1 colspan=1>Medica: Sodium Electrode (Na*)</td><td rowspan=1 colspan=1>Horiba: Sodium Electrode (Na*)</td></tr><tr><td rowspan=1 colspan=1>Medica: Potassium (K+)</td><td rowspan=1 colspan=1>Horiba: Potassium (K+)</td></tr><tr><td rowspan=1 colspan=1>Medica: Chloride (CI-)</td><td rowspan=1 colspan=1>Horiba: Chloride (CI-)</td></tr><tr><td rowspan=1 colspan=1>Medica: CAL A</td><td rowspan=1 colspan=1>Horiba: L-Solution</td></tr><tr><td rowspan=1 colspan=1>Medica: CAL B (Calibrator)</td><td rowspan=1 colspan=1>Horiba: H-Solution (Calibrator)</td></tr><tr><td rowspan=1 colspan=1>Medica: Clean Solution</td><td rowspan=1 colspan=1>Horiba: Clean Solution</td></tr><tr><td rowspan=1 colspan=1>Medica: Urine Diluent (for urine ISE)</td><td rowspan=1 colspan=1>Horiba: Urine Diluent (for urine ISE)</td></tr><tr><td rowspan=1 colspan=1>Y</td><td rowspan=1 colspan=1>Horiba: Etching Solution</td></tr><tr><td rowspan=1 colspan=1>Y</td><td rowspan=1 colspan=1>Horiba: Ref-Solution</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>SampleVolume</td><td rowspan=1 colspan=1>70ul</td><td rowspan=1 colspan=1>53ul</td></tr><tr><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>CalibrationType</td><td rowspan=1 colspan=1>2-Point(CAL A + CAL B)</td><td rowspan=1 colspan=1>2-Point(L-solution + H-Solution)</td></tr><tr><td></td><td></td><td></td></tr><tr><td rowspan=2 colspan=1>Analysis Time</td><td rowspan=1 colspan=1>Serum - 30s including 1-point calibration</td><td rowspan=1 colspan=1>Serum - 36s including 1 point calibration</td></tr><tr><td rowspan=1 colspan=1>Urine - 60s including 1-point calibration</td><td rowspan=1 colspan=1>Urine - 54s including 1 point calibration</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>ISE ModuleSize</td><td rowspan=1 colspan=1>100mm (H) x 102mm (W) x 91 mm (D)</td><td rowspan=1 colspan=1>175mm (H) x 205mm (W) x 95 mm (D)</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>MaximumEnvironmentalTemperature(UnopenedStorage)</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>45°</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=3 colspan=1>CalibrationPass Range</td><td rowspan=1 colspan=1>Na* pass range (50 mV - 66 mV)</td><td rowspan=1 colspan=1>Na* pass range (38 mV - 65 mV)</td></tr><tr><td rowspan=1 colspan=1>K+ pass range (50 mV - 63 mV)</td><td rowspan=1 colspan=1>K+ pass range (37 mV - 67 mV)</td></tr><tr><td rowspan=1 colspan=1>Cl- pass range (40 mV - 59 mV)</td><td rowspan=1 colspan=1>Cl- pass range (28 mV - 53 mV)</td></tr></table>

ANALYTICAL PERFORMANCE:

# Precision/Reproducibility:

Precision was evaluated consistent with C.L.S.I document EP05-A3 ‘Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline- Third Edition.’ Serum precision studies were performed on two RX imola systems using two levels of control material and at least five human serum samples for Sodium, Potassium and Chloride. Urine precision studies were performed on the same two RX imola systems for Sodium, Potassium and Chloride using two levels of urine controls and at least five urine patient pools. Testing was conducted twice per day for 20 non-consecutive days. Two replicates per run was performed for each sample.

The results are summarized in the tables below:

# Table 3: Sodium Serum Precision Summary

# Within run precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>SerumPool 1</td><td rowspan=1 colspan=1>SerumPool 2</td><td rowspan=1 colspan=1>SerumPool 3</td><td rowspan=1 colspan=1>SerumPool 4</td><td rowspan=1 colspan=1>SerumPool 5</td><td rowspan=1 colspan=1>SerumPool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>143.72</td><td rowspan=1 colspan=1>160.93</td><td rowspan=1 colspan=1>101.68</td><td rowspan=1 colspan=1>111.00</td><td rowspan=1 colspan=1>118.67</td><td rowspan=1 colspan=1>136.38</td><td rowspan=1 colspan=1>162.38</td><td rowspan=1 colspan=1>192.10</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.88</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>0.69</td><td rowspan=1 colspan=1>0.59</td><td rowspan=1 colspan=1>1.88</td><td rowspan=1 colspan=1>0.47</td><td rowspan=1 colspan=1>2.69</td><td rowspan=1 colspan=1>0.37</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Total precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>SerumPool 1</td><td rowspan=1 colspan=1>SerumPool 2</td><td rowspan=1 colspan=1>SerumPool 3</td><td rowspan=1 colspan=1>SerumPool 4</td><td rowspan=1 colspan=1>SerumPool 5</td><td rowspan=1 colspan=1>SerumPool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>143.72</td><td rowspan=1 colspan=1>160.93</td><td rowspan=1 colspan=1>101.68</td><td rowspan=1 colspan=1>111.00</td><td rowspan=1 colspan=1>118.67</td><td rowspan=1 colspan=1>136.38</td><td rowspan=1 colspan=1>162.38</td><td rowspan=1 colspan=1>192.10</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>1.57</td><td rowspan=1 colspan=1>2.17</td><td rowspan=1 colspan=1>2.11</td><td rowspan=1 colspan=1>1.39</td><td rowspan=1 colspan=1>2.37</td><td rowspan=1 colspan=1>1.63</td><td rowspan=1 colspan=1>3.61</td><td rowspan=1 colspan=1>3.71</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Table 4: Potassium Serum Precision Summary

# Within run precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>SerumPool 1</td><td rowspan=1 colspan=1>SerumPool 2</td><td rowspan=1 colspan=1>SerumPool 3</td><td rowspan=1 colspan=1>SerumPool 4</td><td rowspan=1 colspan=1>SerumPool 5</td><td rowspan=1 colspan=1>SerumPool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>4.00</td><td rowspan=1 colspan=1>6.43</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>2.16</td><td rowspan=1 colspan=1>3.26</td><td rowspan=1 colspan=1>4.56</td><td rowspan=1 colspan=1>6.58</td><td rowspan=1 colspan=1>9.73</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>1.9</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Total precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>SerumPool 1</td><td rowspan=1 colspan=1>SerumPool 2</td><td rowspan=1 colspan=1>SerumPool 3</td><td rowspan=1 colspan=1>SerumPool 4</td><td rowspan=1 colspan=1>SerumPool 5</td><td rowspan=1 colspan=1>SerumPool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>4.00</td><td rowspan=1 colspan=1>6.43</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>2.16</td><td rowspan=1 colspan=1>3.26</td><td rowspan=1 colspan=1>4.56</td><td rowspan=1 colspan=1>6.58</td><td rowspan=1 colspan=1>9.73</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.20</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>2.1</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Table 5: Chloride Serum Precision Summary

# Within run precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>SerumPool 2</td><td rowspan=1 colspan=1>SerumPool 3</td><td rowspan=1 colspan=1>SerumPool 4</td><td rowspan=1 colspan=1>SerumPool 5</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>98.27</td><td rowspan=1 colspan=1>120.99</td><td rowspan=1 colspan=1>83.30</td><td rowspan=1 colspan=1>96.14</td><td rowspan=1 colspan=1>117.38</td><td rowspan=1 colspan=1>161.10</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.68</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>0.79</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=1>0.50</td><td rowspan=1 colspan=1>0.74</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Total precision

Page 6 of 15   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>SerumPool 2</td><td rowspan=1 colspan=1>SerumPool 3</td><td rowspan=1 colspan=1>SerumPool 4</td><td rowspan=1 colspan=1>SerumPool 5</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>98.27</td><td rowspan=1 colspan=1>120.99</td><td rowspan=1 colspan=1>83.30</td><td rowspan=1 colspan=1>96.14</td><td rowspan=1 colspan=1>117.38</td><td rowspan=1 colspan=1>161.10</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=1>1.54</td><td rowspan=1 colspan=1>1.85</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>1.06</td><td rowspan=1 colspan=1>3.55</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>2.2</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Confidential

# Table 6: Sodium Urine Precision Summary

# Within run precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>UrinePool 2</td><td rowspan=1 colspan=1>UrinePool 3</td><td rowspan=1 colspan=1>UrinePool 4</td><td rowspan=1 colspan=1>UrinePool 5</td><td rowspan=1 colspan=1>UrinePool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>65.45</td><td rowspan=1 colspan=1>215.33</td><td rowspan=1 colspan=1>84.72</td><td rowspan=1 colspan=1>118.01</td><td rowspan=1 colspan=1>179.59</td><td rowspan=1 colspan=1>257.99</td><td rowspan=1 colspan=1>285.71</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>2.48</td><td rowspan=1 colspan=1>2.83</td><td rowspan=1 colspan=1>1.91</td><td rowspan=1 colspan=1>2.41</td><td rowspan=1 colspan=1>3.08</td><td rowspan=1 colspan=1>2.88</td><td rowspan=1 colspan=1>2.77</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Total precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>UrinePool 2</td><td rowspan=1 colspan=1>UrinePool 3</td><td rowspan=1 colspan=1>UrinePool 4</td><td rowspan=1 colspan=1>UrinePool 5</td><td rowspan=1 colspan=1>UrinePool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>65.45</td><td rowspan=1 colspan=1>215.33</td><td rowspan=1 colspan=1>84.72</td><td rowspan=1 colspan=1>118.01</td><td rowspan=1 colspan=1>179.59</td><td rowspan=1 colspan=1>257.99</td><td rowspan=1 colspan=1>285.71</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>3.85</td><td rowspan=1 colspan=1>8.94</td><td rowspan=1 colspan=1>3.18</td><td rowspan=1 colspan=1>3.19</td><td rowspan=1 colspan=1>4.71</td><td rowspan=1 colspan=1>6.11</td><td rowspan=1 colspan=1>7.16</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>5.9</td><td rowspan=1 colspan=1>4.2</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>2.5</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Table 7: Potassium Urine Precision Summary

# Within run precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>UrinePool 2</td><td rowspan=1 colspan=1>UrinePool 3</td><td rowspan=1 colspan=1>UrinePool 4</td><td rowspan=1 colspan=1>UrinePool 5</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>34.49</td><td rowspan=1 colspan=1>144.18</td><td rowspan=1 colspan=1>33.54</td><td rowspan=1 colspan=1>85.89</td><td rowspan=1 colspan=1>122.59</td><td rowspan=1 colspan=1>160.81</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.32</td><td rowspan=1 colspan=1>0.93</td><td rowspan=1 colspan=1>0.21</td><td rowspan=1 colspan=1>0.82</td><td rowspan=1 colspan=1>0.77</td><td rowspan=1 colspan=1>1.73</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.1</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Total precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>UrinePool 2</td><td rowspan=1 colspan=1>UrinePool 3</td><td rowspan=1 colspan=1>UrinePool 4</td><td rowspan=1 colspan=1>UrinePool 5</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>34.49</td><td rowspan=1 colspan=1>144.18</td><td rowspan=1 colspan=1>33.54</td><td rowspan=1 colspan=1>85.89</td><td rowspan=1 colspan=1>122.59</td><td rowspan=1 colspan=1>160.81</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.77</td><td rowspan=1 colspan=1>4.80</td><td rowspan=1 colspan=1>0.73</td><td rowspan=1 colspan=1>2.49</td><td rowspan=1 colspan=1>4.10</td><td rowspan=1 colspan=1>6.50</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>4.0</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Confidential

Table 8: Chloride Urine Precision Summary

# Within run precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>UrinePool 1</td><td rowspan=1 colspan=1>UrinePool 2</td><td rowspan=1 colspan=1>UrinePool 3</td><td rowspan=1 colspan=1>UrinePool 4</td><td rowspan=1 colspan=1>UrinePool 5</td><td rowspan=1 colspan=1>UrinePool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>86.04</td><td rowspan=1 colspan=1>280.01</td><td rowspan=1 colspan=1>85.63</td><td rowspan=1 colspan=1>93.06</td><td rowspan=1 colspan=1>146.38</td><td rowspan=1 colspan=1>198.19</td><td rowspan=1 colspan=1>247.72</td><td rowspan=1 colspan=1>315.40</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>2.28</td><td rowspan=1 colspan=1>2.68</td><td rowspan=1 colspan=1>1.91</td><td rowspan=1 colspan=1>2.13</td><td rowspan=1 colspan=1>2.19</td><td rowspan=1 colspan=1>2.41</td><td rowspan=1 colspan=1>2.69</td><td rowspan=1 colspan=1>4.24</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Total precision

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Control1</td><td rowspan=1 colspan=1>Control2</td><td rowspan=1 colspan=1>UrinePool 1</td><td rowspan=1 colspan=1>UrinePool 2</td><td rowspan=1 colspan=1>UrinePool 3</td><td rowspan=1 colspan=1>UrinePool 4</td><td rowspan=1 colspan=1>UrinePool 5</td><td rowspan=1 colspan=1>UrinePool 6</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/l)</td><td rowspan=1 colspan=1>86.04</td><td rowspan=1 colspan=1>280.01</td><td rowspan=1 colspan=1>85.63</td><td rowspan=1 colspan=1>93.06</td><td rowspan=1 colspan=1>146.38</td><td rowspan=1 colspan=1>198.19</td><td rowspan=1 colspan=1>247.72</td><td rowspan=1 colspan=1>315.40</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>2.93</td><td rowspan=1 colspan=1>7.57</td><td rowspan=1 colspan=1>2.97</td><td rowspan=1 colspan=1>3.33</td><td rowspan=1 colspan=1>3.67</td><td rowspan=1 colspan=1>4.53</td><td rowspan=1 colspan=1>7.66</td><td rowspan=1 colspan=1>8.12</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>2.6</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80</td></tr></table>

# Precision Conclusion

The acceptance criteria for precision was met for serum and urine for all analytes (Sodium, Potassium and Chloride) on the RX imola with the modified ISE device.

# Linearity/assay reportable range:

Linearity studies have been carried out in serum and urine in accordance with C.L.S.I. standard EP6-A ‘Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline’. Linearity studies were performed at 9 levels to determine the analytical range of an assay - that is the range where the reported result is a linear function to the analyte concentration (or where deviation from linearity is less than $5 \%$ ).

The linearity samples were prepared at 9 levels to cover the measuring intervals in the table below.

Table 9: Linearity Results Summary   

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Measuring Interval (mmol/L)</td></tr><tr><td rowspan=2 colspan=1>Sodium</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>90 to 200</td></tr><tr><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>45 to 318</td></tr><tr><td rowspan=2 colspan=1>Potassium</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0.5 to 11</td></tr><tr><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>7 to 168</td></tr><tr><td rowspan=2 colspan=1>Chloride</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>72 to 210</td></tr><tr><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>61 to 319</td></tr></table>

# Linearity Conclusion

The results of the linearity studies support the above claimed measuring ranges for serum and urine for all analytes (Sodium, Potassium and Chloride) on the RX imola with the modified ISE device.

# Specificity/Interference

Evaluation of specificity/interference was carried out in serum and urine in accordance with EP07 3rd Edition ‘Interference Testing in Clinical Chemistry.’ The analytes below were tested in serum up to the following levels and were found not to interfere with Sodium, Potassium and Chloride determination.

ISE Sodium, Potassium and Chloride Interference Summary (in Serum) The analytes below were added to normal serum and found not to interfere up to the following levels.

Table 10: Analytes Added to Normal Serum Level 1   

<table><tr><td rowspan=1 colspan=1>cYanmaGYelowb</td><td rowspan=1 colspan=1>Sodium - 130 mmol/lI</td><td rowspan=1 colspan=1>Potassium - 3 mmol/l</td><td rowspan=1 colspan=1>Chloride - 90 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Haemoglobin</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>126 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Conjugate Bilirubin</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>49.5 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Intralipid</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr></table>

Table 11: Analytes Added to Normal Serum Level 2   

<table><tr><td rowspan=1 colspan=1>cYanmaGYellowb</td><td rowspan=1 colspan=1>Sodium - 150 mmol/l</td><td rowspan=1 colspan=1>Potassium - 5 mmol/l</td><td rowspan=1 colspan=1>Chloride - 110 mmol/I</td></tr><tr><td rowspan=1 colspan=1>Haemoglobin</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>205 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Conjugate Bilirubin</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Intralipid</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr></table>

Table 12: Exogenous Interferences in Serum - Level 1   

<table><tr><td rowspan=1 colspan=1>InterferingSubbstance</td><td rowspan=1 colspan=1>Sodium 130 mmol/l</td><td rowspan=1 colspan=1>Potassium 3 mmol/I</td><td rowspan=1 colspan=1>Chloride 90 mmol/I</td></tr><tr><td rowspan=1 colspan=1>Bromide</td><td rowspan=1 colspan=1>37.5 mmol/l</td><td rowspan=1 colspan=1>37.5 mmol/l</td><td rowspan=1 colspan=1>37.5 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>341 µmol/L</td><td rowspan=1 colspan=1>341 μmol/L</td><td rowspan=1 colspan=1>341 µmol/L</td></tr><tr><td rowspan=1 colspan=1>Thiocyanate</td><td rowspan=1 colspan=1>6.88 mmol/l</td><td rowspan=1 colspan=1>0.8 mmol/l</td><td rowspan=1 colspan=1>1.12 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Lithium</td><td rowspan=1 colspan=1>3.2 mmol/l</td><td rowspan=1 colspan=1>3.2 mmol/l</td><td rowspan=1 colspan=1>3.2 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Salicylic Acid</td><td rowspan=1 colspan=1>4.3 mmol/l</td><td rowspan=1 colspan=1>4.3 mmol/l</td><td rowspan=1 colspan=1>4.3 mmol/l</td></tr></table>

Table 13: Exogenous Interferences in Serum - Level 2   

<table><tr><td rowspan=1 colspan=1>InterferingSubstance</td><td rowspan=1 colspan=1>Sodium 150 mmol/I</td><td rowspan=1 colspan=1>Potassium 5 mmol/I</td><td rowspan=1 colspan=1>Chloride 110 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Bromide</td><td rowspan=1 colspan=1>37.5 mmol/l</td><td rowspan=1 colspan=1>37.5 mmol/l</td><td rowspan=1 colspan=1>37.5 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>341 μmol/L</td><td rowspan=1 colspan=1>341 µmol/L</td><td rowspan=1 colspan=1>341 µmol/L</td></tr><tr><td rowspan=1 colspan=1>Thiocyanate</td><td rowspan=1 colspan=1>6.88 mmol/l</td><td rowspan=1 colspan=1>0.85 mmol/|</td><td rowspan=1 colspan=1>1.25 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Lithium</td><td rowspan=1 colspan=1>3.2 mmol/l</td><td rowspan=1 colspan=1>3.2 mmol/l</td><td rowspan=1 colspan=1>3.2 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Salicylic Acid</td><td rowspan=1 colspan=1>4.3 mmol/l</td><td rowspan=1 colspan=1>4.3 mmol/l</td><td rowspan=1 colspan=1>4.3 mmol/l</td></tr></table>

# ISE Sodium, Potassium and Chloride Urine Interference (in urine) summary

The analytes below were added to normal urine and found not to interfere up to the following levels.

Table 14: Analytes Added to Normal Urine Specificity/Interference Level 1   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sodium 40 mmol/lI</td><td rowspan=1 colspan=1>Potassium 25 mmol/lI</td><td rowspan=1 colspan=1>Chloride 110 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Haemoglobin</td><td rowspan=1 colspan=1>590 mg/dl</td><td rowspan=1 colspan=1>765 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>17.4 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Conjugate Bilirubin</td><td rowspan=1 colspan=1>22 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>44.5 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>ntralipid</td><td rowspan=1 colspan=1>810 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr></table>

Table 15: Analytes Added to Normal Urine Specificity/Interference Level 2   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sodium 220 mmol/l</td><td rowspan=1 colspan=1>Potassium 125 mmol/lI</td><td rowspan=1 colspan=1>Chloride 250 mmol/lI</td></tr><tr><td rowspan=1 colspan=1>Haemoglobin</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Conjugate Bilirubin</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td><td rowspan=1 colspan=1>60 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>ntralipia</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr></table>

Table 16: Exogenous Interferences in Urine - Level 1   

<table><tr><td rowspan=1 colspan=1>InterferingSubstance</td><td rowspan=1 colspan=1>Sodium 40 mmol/l</td><td rowspan=1 colspan=1>Potassium 25 mmol/l</td><td rowspan=1 colspan=1>Chloride 110 mmol/l</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>200 mg/dl</td><td rowspan=1 colspan=1>200 mg/dl</td><td rowspan=1 colspan=1>200 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Boric Acid</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>GammaGlobulin</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>HSA</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td></tr></table>

Table 17: Exogenous Interferences Level 2 (Urine)   

<table><tr><td rowspan=1 colspan=1>InterferingSubstance</td><td rowspan=1 colspan=1>Sodium 220 mmol/lI</td><td rowspan=1 colspan=1>Potassium 125 mmol/I</td><td rowspan=1 colspan=1>Chloride 250 mmol/I</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>200 mg/dl</td><td rowspan=1 colspan=1>200 mg/dl</td><td rowspan=1 colspan=1>200 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Boric Acid</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td><td rowspan=1 colspan=1>1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Gamma Globulin</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>HSA</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td><td rowspan=1 colspan=1>500 mg/dl</td></tr></table>

# Method comparison with predicate device:

Correlation studies were carried out for serum and urine in accordance with C.L.S.I. guideline EP09c ‘Measurement Procedure Comparison and Bias Estimation Using Patient Samples; Approved Guideline- Third Edition’. A method comparison was conducted against the unmodified device (cleared under k052914) to confirm the device is substantially equivalent. Testing was conducted on two RX imola analysers, one RX imola analyser with the modified device, and the other RX imola analyser with the unmodified device.

# Correlation (Serum)

# Sodium

This method – RX imola new ISE unit (Y) was compared with method on the RX imola with previous ISE unit $( \mathsf { X } )$ and the following linear regression equation obtained: -

$$
\begin{array} { l } { { \Upsilon = 1 . 0 6 \times - 8 . 4 } } \\ { { { } } } \\ { { { \mathsf { R } } = 0 . 9 7 3 } } \end{array}
$$

105 patient serum samples were analysed spanning the range 111.7 to 195.8 mmol/l.

# Potassium

This method – RX imola new ISE unit (Y) was compared with method on the RX imola with previous ISE unit $( \mathsf { X } )$ and the following linear regression equation obtained: -

$\mathsf { R } = 0 . 9 9 8$

109 patient serum samples were analysed spanning the range 0.96 to 10.63 mmol/l.

# Chloride

This method – RX imola new ISE unit (Y) was compared with method on the RX imola with previous ISE unit $( \mathsf { X } )$ and the following linear regression equation obtained: -

$$
\mathsf { Y } = 1 . 0 3 \mathsf { x } - 6 . 5 9
$$

104 patient serum samples were analysed spanning the range 86.2 to 196.2 mmol/l.

# RANDOX

# Correlation (Urine)

# Sodium

This method – RX imola new ISE unit (Y) was compared with method on the RX imola with previous ISE unit (X) and the following linear regression equation obtained: -

$$
\ Y = 0 . 9 2 x + 6 . 4 3
$$

72 patient urine samples were analysed spanning the range 49.4 to 298.6 mmol/l.

# Potassium

This method – RX imola new ISE unit (Y) was compared with method on the RX imola with previous ISE unit $( \mathsf { X } )$ and the following linear regression equation obtained: -

$$
\mathsf { Y } = 1 . 0 3 \mathsf { x } - 1 . 0 2
$$

84 patient urine samples were analysed spanning the range 9.5 to 167.6 mmol/l.

# Chloride

This method – RX imola new ISE unit (Y) was compared with method on the RX imola with previous ISE unit $( \mathsf { X } )$ and the following linear regression equation obtained: -

$$
\Upsilon = 0 . 8 9 x + 1 8 . 4 9
$$

90 patient urine samples were analysed spanning the range 84.8 – 226.8 mmol/l.

# DESIGN CONTROL ACTIVITIES

The verification and validation of the device modification has been performed under design control. The design control activities were based on the risk analysis and acceptance criteria were set to maintain the performance and safety of the device. The verification and validation includes in-house studies of precision, method comparison, interferences and linearity.

Confidential

# RISK ANALYSIS

A Risk Analysis was performed to identify any new risks associated with the change in the ISE electrodes provided with the RX imola. Based on this and the testing the results indicate that the changes to the ISE unit on the RX imola are safe and effective for the stated intended use and are substantially equivalent to the previously approved device.

# OVERALL CONCLUSION

The modified device is substantially equivalent to the unmodified device (cleared under k052914).